Aclarion Stock Beta
| ACON Stock | USD 0.18 0.01 5.88% |
Aclarion fundamentals help investors to digest information that contributes to Aclarion's financial success or failures. It also enables traders to predict the movement of Aclarion Stock. The fundamental analysis module provides a way to measure Aclarion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aclarion stock.
Aclarion | Beta |
Aclarion Company Beta Analysis
Aclarion's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Aclarion Beta | 0.4 |
Most of Aclarion's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aclarion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aclarion Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Aclarion is extremely important. It helps to project a fair market value of Aclarion Stock properly, considering its historical fundamentals such as Beta. Since Aclarion's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aclarion's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aclarion's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Aclarion has a Beta of 0.396. This is 53.95% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Aclarion Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aclarion's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aclarion could also be used in its relative valuation, which is a method of valuing Aclarion by comparing valuation metrics of similar companies.Aclarion is currently under evaluation in beta category among its peers.
Aclarion Institutional Holders
Institutional Holdings refers to the ownership stake in Aclarion that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aclarion's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aclarion's value.| Shares | Ubs Group Ag | 2024-06-30 | 39.9 K | Geode Capital Management, Llc | 2024-09-30 | 33.9 K | Two Sigma Securities, Llc | 2024-06-30 | 32.1 K | Tower Research Capital Llc | 2024-06-30 | 9.2 K | Bank Of America Corp | 2024-06-30 | 167 | Ground Swell Capital, Llc | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 |
As returns on the market increase, Aclarion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aclarion is expected to be smaller as well.
Aclarion Fundamentals
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (103.51) % | ||||
| Current Valuation | 1.45 M | ||||
| Shares Outstanding | 10.43 M | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 3.57 % | ||||
| Number Of Shares Shorted | 380.86 K | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 34.26 X | ||||
| Revenue | 75.4 K | ||||
| Gross Profit | (4.85 K) | ||||
| EBITDA | (4.14 M) | ||||
| Net Income | (4.91 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | (0.88) X | ||||
| Cash Flow From Operations | (3.65 M) | ||||
| Short Ratio | 0.77 X | ||||
| Earnings Per Share | (2.40) X | ||||
| Target Price | 1.15 | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 1.85 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (44.28 M) | ||||
| Working Capital | (1.9 M) | ||||
| Net Asset | 2.46 M |
About Aclarion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports: Check out Aclarion Piotroski F Score and Aclarion Altman Z Score analysis. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.40) | Revenue Per Share 0.015 | Quarterly Revenue Growth (0.36) | Return On Assets (1.15) | Return On Equity (7.14) |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.